4//SEC Filing
SUTARIA RAVI 4
Accession 0001239133-06-000001
CIK 0000893970other
Filed
Jul 12, 8:00 PM ET
Accepted
Jul 13, 3:12 PM ET
Size
9.2 KB
Accession
0001239133-06-000001
Insider Transaction Report
Form 4
SUTARIA RAVI
10% Owner
Transactions
- Conversion
Common Stock
2006-05-25+7,843,465→ 2,000,000 total - Conversion
Series K Convertible Preferred Stock
2006-05-25−366,141→ 0 total→ Common Stock
Holdings
- 10,518,645(indirect: By LLC)
Common Stock
Footnotes (2)
- [F1]On May 25, 2006, Ravis Holdings I, LLC, a New York limited liability company of which Ravi Sutaria is the sole member, converted an aggregate of 366,141 shares of Interpharm Holdings, Inc. ("Interpharm") Series K Convertible Preferred Stock ("Series K Stock") into an aggregate of 7,843,465 shares of Common Stock of Interpharm ("Common Stock"), at a conversion rate of approximately 21.47 shares of Common Stock issued for each share of Series K Stock converted.
- [F2]On June 4, 2004, all conditions for the conversion of the Series K Stock were met, making that date the "Trigger Date" as defined in the Certificate of Designations of the Series K Stock. After the Trigger Date the Series K Stock was to convert ratably over a seven year period into Common Stock. One-seventh of the outstanding shares of Series K Stock converted into Common Stock on each of June 4, 2004 and June 4, 2005, at a conversion rate of approximately 21.47 shares of Common Stock issued for each share of Series K Stock converted. On May 25, 2006 Interpharm agreed with all of the holders of Series K Stock, including Ravis Holdings I, LLC, that all of the outstanding shares of Series K Stock then outstanding would immediately convert into Common Stock at the same conversion rate.
Documents
Issuer
INTERPHARM HOLDINGS INC
CIK 0000893970
Entity typeother
Related Parties
1- filerCIK 0001239133
Filing Metadata
- Form type
- 4
- Filed
- Jul 12, 8:00 PM ET
- Accepted
- Jul 13, 3:12 PM ET
- Size
- 9.2 KB